Article
[Molecular Markers of Prognosis in Myelodysplastic Syndromes--Review].
Zhongguo shi yan xue ye xue za zhi - 1 Feb 2016
Xu Yuan-Yuan, Yu Li
Abstract excerpt
Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders, which have a wide range of clinical manifestations and eventual outcomes. It is useful to predict its risk for patients prognosis. The International Prognostic Scoring System (IPSS) has been the standard tool used to stratify MDS patients since 1997. Other models have been created to improve upon the IPSS.With the application of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
